Back to Index
Brenda Elaine Jones, MD
Clinical Associate Professor of Medicine (Part Time)
EDM 120 Health Sciences Campus Los Angeles
+1 323 224 5014


Dr. Jones is the USC Principal Investigator of the tuberculosis (TB) diagnostic study, "Evaluation of the 4th Generation Quantiferon TB Test (CST001) for the Detection of Tuberculosis Infection." The 4th Generation Quantiferon TB test aims to further increase the sensitivity of the assay in immunocompromised patients as well as to possibly aid in differentiating latent TB infection from active TB disease.

Dr. Jones earned her medical degree from Howard University School of Medicine. She then went on to complete her fellowship and post doctoral research at USC, specializing in Infectious Diseases and Hematology.


National Merit Scholar

American Society for Microbiology: Saber Fellowship Award, 1991

Western Society for Clinical Investigation: Elected Member, 2008

AIDS Healthcare Foundation: Golden Heart Award, 1991


Escalante P, Kooda KJ, Khan R, Aye SS, Christianakis S, Arkfeld DG, Ehresmann GR, Kort JJ, Jones BE. Diagnosis of Latent Tuberculosis Infection with T-SPOT(®). TB in a Predominantly Immigrant Population with Rheumatologic Disorders. Lung. 2015 Feb; 193(1):3-11. View in: PubMed

Sattah MV, Aye SS, Azen C, Kort JJ, Escalante P, Jones BE. Interferon-gamma release assay T-SPOT®. TB and HIV-related tuberculosis. Int J Tuberc Lung Dis. 2012 Feb; 16(2):281-2. View in: PubMed

Slotar D, Escalante P, Jones BE. Pulmonary manifestations of HIV/AIDS in the tropics. Clin Chest Med. 2002 Jun; 23(2):355-67. View in: PubMed

Powered bySC CTSI